0001213900-22-065696.txt : 20221024 0001213900-22-065696.hdr.sgml : 20221024 20221024101540 ACCESSION NUMBER: 0001213900-22-065696 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221021 FILED AS OF DATE: 20221024 DATE AS OF CHANGE: 20221024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novak Alfred J CENTRAL INDEX KEY: 0001388862 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40804 FILM NUMBER: 221325032 MAIL ADDRESS: STREET 1: 325 NE 6TH ST CITY: BOCA RATON STATE: FL ZIP: 33432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pasithea Therapeutics Corp. CENTRAL INDEX KEY: 0001841330 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851591963 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2110 NARCISSUS CT CITY: VENICE STATE: CA ZIP: 90291 BUSINESS PHONE: 8184226172 MAIL ADDRESS: STREET 1: 2110 NARCISSUS CT CITY: VENICE STATE: CA ZIP: 90291 4 1 ownership.xml X0306 4 2022-10-21 0 0001841330 Pasithea Therapeutics Corp. KTTA 0001388862 Novak Alfred J 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 1 0 0 0 Stock Option (to acquire Common Stock) 1.06 2022-10-21 4 A 0 100000 0 A 2023-10-21 2032-10-21 Common Stock 100000 100000 D The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to Mr. Novak's continued service as a director, one-half vesting on the first anniversary of the grant date, and the remaining 50% vesting on the second anniversary of the grant date. /s/ Alfred J. Novak 2022-10-24